These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30190449)

  • 1. Effect of Immunosuppressive Therapy on the Occurrence of Atypical Hemolytic Uremic Syndrome in Renal Transplant Recipients.
    Raina R; Chauvin A; Fox K; Kesav N; Ascha M; Vachharajani TJ; Krishnappa V
    Ann Transplant; 2018 Sep; 23():631-638. PubMed ID: 30190449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.
    Duineveld C; Verhave JC; Berger SP; van de Kar NCAJ; Wetzels JFM
    Am J Kidney Dis; 2017 Dec; 70(6):770-777. PubMed ID: 28821363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical hemolytic uremic syndrome diagnosed four years after ABO-incompatible kidney transplantation.
    Kawaguchi K; Kawanishi K; Sato M; Itabashi M; Fujii A; Kanetsuna Y; Huchinoue S; Ohashi R; Koike J; Honda K; Nagashima Y; Nitta K
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():61-5. PubMed ID: 26031589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recurrent atypical hemolytic uremic syndrome after renal transplantation: treatment with eculizumab].
    Latzke AB; Fernández P; Chiurchiu C; Sarmantano D; De Arteaga J; Douthat W; De la Fuente J
    Medicina (B Aires); 2018; 78(2):119-122. PubMed ID: 29659362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midterm Outcomes of 12 Renal Transplant Recipients Treated With Eculizumab to Prevent Atypical Hemolytic Syndrome Recurrence.
    Levi C; Frémeaux-Bacchi V; Zuber J; Rabant M; Devriese M; Snanoudj R; Scemla A; Amrouche L; Mejean A; Legendre C; Sberro-Soussan R
    Transplantation; 2017 Dec; 101(12):2924-2930. PubMed ID: 28858176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Eculizumab Therapy for Atypical Hemolytic Uremic Syndrome Recurrence and Antibody-Mediated Rejection Progress After Renal Transplantation With Preformed Donor-Specific Antibodies: Case Report.
    Yamamoto T; Watarai Y; Futamura K; Okada M; Tsujita M; Hiramitsu T; Goto N; Narumi S; Takeda A; Kobayashi T
    Transplant Proc; 2017; 49(1):159-162. PubMed ID: 28104125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical hemolytic uremic syndrome recurrence after kidney transplantation.
    Matar D; Naqvi F; Racusen LC; Carter-Monroe N; Montgomery RA; Alachkar N
    Transplantation; 2014 Dec; 98(11):1205-12. PubMed ID: 24933457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult Post-Kidney Transplant Familial Atypical Hemolytic Uremic Syndrome Successfully Treated With Eculizumab: A Case Report and Literature Review.
    Salameh H; Abu Omar M; Alhariri A; Kisra S; Qasem A; Abdulhak AB
    Am J Ther; 2016; 23(4):e1110-5. PubMed ID: 25486517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney Transplantation in Patients with Atypical Hemolytic Uremic Syndrome due to Complement Factor H Deficiency: Impact of Liver Transplantation.
    Kim S; Park E; Min SI; Yi NJ; Ha J; Ha IS; Cheong HI; Kang HG
    J Korean Med Sci; 2018 Jan; 33(1):e4. PubMed ID: 29215813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atypical hemolytic uremic syndrome].
    Sepúlveda RA; Tagle R; Jara A
    Rev Med Chil; 2018 Jun; 146(6):770-779. PubMed ID: 30148909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haploidentical Hematopoietic Stem Cell Transplant Complicated by Atypical Hemolytic Uremic Syndrome and Kidney Transplant From the Same Donor With No Immunosuppression but C5 Inhibition.
    Ardissino G; Cresseri D; Giglio F; Onida F; Iannuzzella F; Tel F; Giussani A; Messa P; Longhi S; Vincenti D; Tedeschi S; Cugno M; Ciceri F
    Transplantation; 2019 Feb; 103(2):e48-e51. PubMed ID: 30365467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea.
    Cheong HI; Jo SK; Yoon SS; Cho H; Kim JS; Kim YO; Koo JR; Park Y; Park YS; Shin JI; Yoo KH; Oh D
    J Korean Med Sci; 2016 Oct; 31(10):1516-28. PubMed ID: 27550478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical guides for atypical hemolytic uremic syndrome in Japan.
    Kato H; Nangaku M; Hataya H; Sawai T; Ashida A; Fujimaru R; Hidaka Y; Kaname S; Maruyama S; Yasuda T; Yoshida Y; Ito S; Hattori M; Miyakawa Y; Fujimura Y; Okada H; Kagami S;
    Pediatr Int; 2016 Jul; 58(7):549-55. PubMed ID: 27460397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preemptive plasma therapy prevents atypical hemolytic uremic syndrome relapse in kidney transplant recipients.
    Aigner C; Böhmig GA; Eskandary F; Herkner H; Prohászka Z; Csuka D; Kain R; Gaggl M; Sunder-Plassmann R; Müller-Sacherer T; Oszwald A; Fischer G; Schmidt A; Sunder-Plassmann G
    Eur J Intern Med; 2020 Mar; 73():51-58. PubMed ID: 31791575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living kidney transplantation in adult patients with atypical haemolytic uraemic syndrome.
    Verhave JC; Westra D; van Hamersvelt HW; van Helden M; van de Kar NC; Wetzels JF
    Neth J Med; 2013 Sep; 71(7):342-7. PubMed ID: 24038559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into postrenal transplant hemolytic uremic syndrome.
    Zuber J; Le Quintrec M; Sberro-Soussan R; Loirat C; Frémeaux-Bacchi V; Legendre C
    Nat Rev Nephrol; 2011 Jan; 7(1):23-35. PubMed ID: 21102542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Atypical hemolytic uremic syndrome].
    Blasco Pelicano M; Rodríguez de Córdoba S; Campistol Plana JM
    Med Clin (Barc); 2015 Nov; 145(10):438-45. PubMed ID: 25433773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases.
    Fakhouri F; Delmas Y; Provot F; Barbet C; Karras A; Makdassi R; Courivaud C; Rifard K; Servais A; Allard C; Besson V; Cousin M; Châtelet V; Goujon JM; Coindre JP; Laurent G; Loirat C; Frémeaux-Bacchi V
    Am J Kidney Dis; 2014 Jan; 63(1):40-8. PubMed ID: 24021908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peri- and Post-operative Evaluation and Management of Atypical Hemolytic Uremic Syndrome (aHUS) in Kidney Transplantation.
    Java A
    Adv Chronic Kidney Dis; 2020 Mar; 27(2):128-137. PubMed ID: 32553245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetics of aHUS and transplant recurrence].
    Bresin E
    G Ital Nefrol; 2015; 32 Suppl 64():. PubMed ID: 26479051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.